PURPOSE: To review the current knowledge regarding the pathogenesis of proliferative diabetic vitreoretinopathy (PDVR) and to present recommendations for its clinical staging. DESIGN: Focused literature review and authors' clinical experience. RESULTS: Although several biochemical mediators may be responsible for the pathogenesis of PDVR, no common biochemical pathway exists. Of those mediators, vascular endothelial growth factor is the one most studied so far. However, since in proliferative diabetic retinopathy (PDR) the thickened posterior vitreous cortex is one of the main factors in the development of proliferations, a consequent shrinkage of the posterior vitreous cortex leads to hemorrhages and tractive retinal detachments. Therefore, PDR should be called PDVR. In consequence, the authors present a new morphological classification of PDVR. CONCLUSIONS: There is no consensus about the biochemical pathway responsible for the progression of PDVR. Although several classifications are described in the literature, the classification suggested here is important in the judgment of, the communication about and the therapy of diabetic retinopathy. Furthermore, it is the only reliable classification for predicting the surgical outcome in diabetics. Copyright (c) 2007 S. Karger AG, Basel.
PURPOSE: To review the current knowledge regarding the pathogenesis of proliferative diabetic vitreoretinopathy (PDVR) and to present recommendations for its clinical staging. DESIGN: Focused literature review and authors' clinical experience. RESULTS: Although several biochemical mediators may be responsible for the pathogenesis of PDVR, no common biochemical pathway exists. Of those mediators, vascular endothelial growth factor is the one most studied so far. However, since in proliferative diabetic retinopathy (PDR) the thickened posterior vitreous cortex is one of the main factors in the development of proliferations, a consequent shrinkage of the posterior vitreous cortex leads to hemorrhages and tractive retinal detachments. Therefore, PDR should be called PDVR. In consequence, the authors present a new morphological classification of PDVR. CONCLUSIONS: There is no consensus about the biochemical pathway responsible for the progression of PDVR. Although several classifications are described in the literature, the classification suggested here is important in the judgment of, the communication about and the therapy of diabetic retinopathy. Furthermore, it is the only reliable classification for predicting the surgical outcome in diabetics. Copyright (c) 2007 S. Karger AG, Basel.
Authors: David G Telander; Shawn A Morales; Sergey Mareninov; Krisztina Forward; Lynn K Gordon Journal: Curr Eye Res Date: 2011-06 Impact factor: 2.424
Authors: Anastasios Georgiadis; Marion Tschernutter; James W B Bainbridge; Kamaljit S Balaggan; Freya Mowat; Emma L West; Peter M G Munro; Adrian J Thrasher; Karl Matter; Maria S Balda; Robin R Ali Journal: PLoS One Date: 2010-12-30 Impact factor: 3.240
Authors: Hyung Cho; Ahmad A Alwassia; Caio V Regiatieri; Jason Y Zhang; Caroline Baumal; Nadia Waheed; Jay S Duker Journal: Retina Date: 2013-03 Impact factor: 4.256
Authors: Sally L Elshaer; Mohammed A Abdelsaid; Ahmad Al-Azayzih; Parag Kumar; Suraporn Matragoon; Julian J Nussbaum; Azza B El-Remessy Journal: J Diabetes Res Date: 2013-08-12 Impact factor: 4.011